These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15737812)

  • 1. Breakthrough pain in malignant and non-malignant diseases: a review of prevalence, characteristics and mechanisms.
    Svendsen KB; Andersen S; Arnason S; Arnér S; Breivik H; Heiskanen T; Kalso E; Kongsgaard UE; Sjogren P; Strang P; Bach FW; Jensen TS
    Eur J Pain; 2005 Apr; 9(2):195-206. PubMed ID: 15737812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breakthrough pain in opioid-treated chronic non-malignant pain patients referred to a multidisciplinary pain centre: a preliminary study.
    Højsted J; Nielsen PR; Eriksen J; Hansen OB; Sjøgren P
    Acta Anaesthesiol Scand; 2006 Nov; 50(10):1290-6. PubMed ID: 16999839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer and breakthrough pain's impact on a diverse population.
    Montague L; Green CR
    Pain Med; 2009 Apr; 10(3):549-61. PubMed ID: 19254338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition and diagnosis of breakthrough pain.
    Payne R
    Pain Med; 2007; 8 Suppl 1():S3-7. PubMed ID: 17280600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consistent and breakthrough pain in diverse advanced cancer patients: a longitudinal examination.
    Green CR; Montague L; Hart-Johnson TA
    J Pain Symptom Manage; 2009 May; 37(5):831-47. PubMed ID: 19054648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breakthrough pain in the management of chronic persistent pain syndromes.
    Webster LR
    Am J Manag Care; 2008 May; 14(5 Suppl 1):S116-22. PubMed ID: 18611099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generalized and symptom-specific sensitization of chronic itch and pain.
    van Laarhoven AI; Kraaimaat FW; Wilder-Smith OH; van de Kerkhof PC; Cats H; van Riel PL; Evers AW
    J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1187-92. PubMed ID: 17894703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle pain: sensory implications and interaction with motor control.
    Arendt-Nielsen L; Graven-Nielsen T
    Clin J Pain; 2008 May; 24(4):291-8. PubMed ID: 18427227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central pain in multiple sclerosis--prevalence and clinical characteristics.
    Osterberg A; Boivie J; Thuomas KA
    Eur J Pain; 2005 Oct; 9(5):531-42. PubMed ID: 16139182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of breakthrough pain.
    McCarberg BH
    Pain Med; 2007; 8 Suppl 1():S8-13. PubMed ID: 17280601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pain experienced by lung cancer patients: a review of prevalence, causes and pathophysiology.
    Potter J; Higginson IJ
    Lung Cancer; 2004 Mar; 43(3):247-57. PubMed ID: 15165082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiology of cancer pain.
    Goudas LC; Bloch R; Gialeli-Goudas M; Lau J; Carr DB
    Cancer Invest; 2005; 23(2):182-90. PubMed ID: 15813511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, etiology, and management of neuropathic pain in an Indian cancer hospital.
    Jain PN; Chatterjee A; Choudhary AH; Sareen R
    J Pain Palliat Care Pharmacother; 2009; 23(2):114-9. PubMed ID: 19492212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of central neuropathic pain: a combined psychophysical and fMRI study in syringomyelia.
    Ducreux D; Attal N; Parker F; Bouhassira D
    Brain; 2006 Apr; 129(Pt 4):963-76. PubMed ID: 16434417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of hyperexcitability of DRG neurons in neuropathic pain.
    Chung JM; Chung K
    Pain Pract; 2002 Jun; 2(2):87-97. PubMed ID: 17147683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual spinothalamic tract pathways predict development of central pain after spinal cord injury.
    Wasner G; Lee BB; Engel S; McLachlan E
    Brain; 2008 Sep; 131(Pt 9):2387-400. PubMed ID: 18669485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact and management of breakthrough pain in cancer.
    Zeppetella G
    Curr Opin Support Palliat Care; 2009 Mar; 3(1):1-6. PubMed ID: 19365156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer.
    Portenoy RK; Taylor D; Messina J; Tremmel L
    Clin J Pain; 2006; 22(9):805-11. PubMed ID: 17057563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rationale for a multimodal approach in the management of breakthrough cancer pain: a review.
    Soares LG; Chan VW
    Am J Hosp Palliat Care; 2007; 24(5):430-9. PubMed ID: 17582029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.